Clinical expertise, advocacy and enhanced autonomy - Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults.
Clinical expertise, advocacy and enhanced autonomy - Acceptability of a pharmacist-facilitated medicines review intervention for community-dwelling Māori older adults.
复制标题
DOI：
10.1016/j.rcsop.2021.100010
复制
发表时间：
2021-06
期刊：
影响因子：
--
通讯作者：
Martini, Nataly
中科院分区：
文献类型：
--
作者：
Hikaka, Joanna;Jones, Rhys;Hughes, Carmel;Amende, Hunter;Connolly, Martin J.;Martini, Nataly
药剂师促进的药物审查在确定与药物有关的问题方面是有效的，并可以改善老年人药物的适当使用。新西兰奥特罗阿目前的服务不是专门为Māori（新西兰土著人民）开发的，可能会增加Māori和non-Māori之间的健康差距。我们为Māori老年人开发了一种药物审查干预措施，并在可行性研究中对其进行了测试。评估患者对药师促进的Māori老年人药物回顾干预的可接受性。干预包括一个药物教育会议（药剂师和参与者）和一个可选的药物优化会议（药剂师、参与者和处方者）。干预后使用专门为本研究开发的结构化电话访谈评估参与者的可接受性。参与者使用五点李克特量表（强烈同意-强烈不同意；数字分析/报告）对陈述作出回应，该量表侧重于权力/控制、支持机制、干预内容和交付以及感知有用性等主题。采用一般归纳分析法分析与干预价值和改进建议有关的开放式问题。17名参与者于2019年12月至2020年3月参加了可行性研究，并完成了可接受性访谈。参与者认为干预的内容和提供方式是适当的，他们对自己的药物和健康的权力和控制有所改善，他们对自我管理的信心也有所增强。产生了五个主题：来自值得信赖的专业人员的药物知识，“通过Māori，为Māori”加强宣传，增强信心和控制，以及财政和资源影响。由Māori为Māori开发的针对Māori老年人的药剂师促进的药物审查干预措施，对患者参与者是可接受的。参与者重视药剂师提供的临床专业知识和倡导，以及药物知识，控制和自主权的增加。与会者希望这项服务继续进行下去。参与者可以接受Māori为Māori开发的药物评价。Māori老年人认为干预提高了药物知识和自主性。年龄较大的Māori参与者重视药剂师的临床专业知识和宣传。
Pharmacist-facilitated medicines reviews are effective at identifying medicines-related problems and can improve the appropriate use of medicines in older adults. Current services in Aotearoa New Zealand (NZ) are not developed specifically for Māori (Indigenous people of NZ) and may increase health disparities between Māori and non-Māori. We developed a medicines review intervention for and with Māori older adults, and tested it in a feasibility study. To assess patient acceptability of a pharmacist-facilitated medicines review intervention for Māori older adults. The intervention consisted of a medicines education session (pharmacist and participant) and an optional medicines optimisation session (pharmacist, participant, and prescriber). Participant acceptability was assessed post-intervention using a structured telephone interview developed specifically for this study. Participants responded to statements using a five-point Likert scale (strongly agree-strongly disagree; numerical analysis/reporting) which focused on the topics of power/control, support mechanisms, intervention content and delivery, and perceived usefulness. Open-ended questions relating to the intervention value and suggestions for improvement were analysed using general inductive analysis. Seventeen participants took part in the feasibility study from December 2019–March 2020 and all completed the acceptability interview. Participants perceived the intervention content and mode of delivery to be appropriate, and that their power and control over their medicines and health improved and as did their confidence in self-management. Five themes were generated: medicines knowledge from a trusted professional, increased advocacy, ‘by Māori, for Māori’, increased confidence and control, and financial and resource implications. A pharmacist-facilitated medicines review intervention for Māori older adults developed by Māori, for Māori, was acceptable to patient participants. Participants valued the clinical expertise and advocacy provided by the pharmacist, and the increase in medicines knowledge, control and autonomy. Participants wanted the service to continue on an ongoing basis. Medicines reviews developed by Māori, for Māori were acceptable to participants. Older Māori perceived the intervention improved medicines knowledge and autonomy. Older Māori participants valued the pharmacist's clinical expertise and advocacy.
登录
查看更多内容
影响因子：
2.9
作者：
Cooper JA;Cadogan CA;Patterson SM;Kerse N;Bradley MC;Ryan C;Hughes CM
通讯作者：
Hughes CM
制定和评估复杂的干预措施：新的医学研究委员会指南。
DOI：
10.1136/bmj.a1655
发表时间：
2008-09-29
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Craig P;Dieppe P;Macintyre S;Michie S;Nazareth I;Petticrew M;Medical Research Council Guidance
通讯作者：
Medical Research Council Guidance
影响因子：
5.5
作者：
Bowen, Deborah J.;Kreuter, Matthew;Spring, Bonnie;Cofta-Woerpel, Ludmila;Linnan, Laura;Weiner, Diane;Bakken, Suzanne;Kaplan, Cecilia Patrick;Squiers, Linda;Fabrizio, Cecilia;Fernandez, Maria
通讯作者：
Fernandez, Maria
影响因子：
5.4
作者：
Harris, Ricci;Tobias, Martin;Nazroo, James
通讯作者：
Nazroo, James
DOI：
10.1016/j.sapharm.2019.09.059
发表时间：
2020-07-01
影响因子：
3.9
作者：
Milosavljevic, Aleksandra;Aspden, Trudi;Harrison, Jeff
通讯作者：
Harrison, Jeff